New York, NY -- (SBWIRE) -- 01/04/2014 -- CaddyStocks.com is keen to discover penny stocks with the potential to make short and long-term gains. We’ve been improving our skills as traders and analysts for years, and we know – from experience – which indicators to look for. That’s why we’ve been able to choice some of the market’s biggest winners and send them to our followers before the rest of the market has any idea of what hit them. Here are some hot stocks to watch for: Penn National Gaming, Inc(NASDAQ:PENN), Cypress Semiconductor Corporation(NASDAQ:CY), Myriad Genetics, Inc.(NASDAQ:MYGN), Orexigen Therapeutics, Inc.(NASDAQ:OREX).
Penn National Gaming, Inc(NASDAQ:PENN) opened its shares at the price of $14.22 for the day. Its closing price was $14.06 after losing -0.71% for the day. The company traded with the total volume of 1.90 million shares, while its average trading volume remained 1.52 million shares. The beta of PENN stands at 1.06. Penn National Gaming, Inc. (Penn National) is a diversified owner and manager of gaming and pari-mutuel properties.
Has PENN Found The Bottom and Ready To Move Up? Find Out Here
Cypress Semiconductor Corporation(NASDAQ:CY) percentage change surged +1.36% to close at $10.42 with the total traded volume of 1.89 million shares, and average volume of 2.11 million. The 52 week range of the stock remained $8.61 - $13.23, while its day lowest price was $10.22 and it hit its day highest price at $10.45. Cypress Semiconductor Corporation (Cypress), delivers high-performance, mixed-signal and programmable solutions. The Company operates in four segments: Consumer and Computation Division, Data Communications Division, Memory Products Division, and Emerging Technologies and Other.
For How Long CY Gloss will Attract Investors? Find out via this report
Myriad Genetics, Inc.(NASDAQ:MYGN) started its trading session with the price of $21.81 and closed at $21.20 by losing -2.39%. MYGN stocks traded with total volume of 1.87 million shares, while the average trading volume remained 2.71 million shares. The beta of MYGN stands at 0.45. Day range of the stock was $21.16 -$21.96. Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests.
Why Should Investors Buy MYGN After the Recent Fall? Just Go Here and Find Out
Orexigen Therapeutics, Inc.(NASDAQ:OREX) ended its day with the loss of -0.69% and closed at the price of $5.75 after opening at $5.81. Stock traded during its last trading session with the total volume of 1.78 million shares, as compared to its average volume of 3.11 million shares. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
Will OREX Get Buyers Even After The Recent Rally? Find Out Here
CaddyStocks record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
The employees of CaddyStocks.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
The information contained in the website and in any reports is provided on an “as-is” basis and has not been verified by us. All information on profiled companies is provided by such companies, or is available from public sources and no representation; warranty or guaranty is made as to its accuracy or completeness. CaddyStocks.com is under no obligation to update any information or opinions contained herein. Investors should not rely solely on the information presented herein, but rather use such information as a starting point for doing additional independent research on the profiled companies in order to form investment strategies and decisions. Neither CaddyStocks.com nor any of its owners, operators, or affiliates shall be liable to any subscriber or reader for any losses or damages arising from the use of any information contained herein, caused in whole or part by CaddyStocks.com in procuring, compiling, interpreting, reporting, or delivering any of the information contained herein or otherwise delivered.
Read Full Disclaimer at: http://caddystocks.com/disclaimer.html/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)